tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

IRWD Stock Latest News

Ironwood jumps after FDA rejects Zealand short bowel syndrome drug application
The FlyIronwood jumps after FDA rejects Zealand short bowel syndrome drug application
1d ago
IRWD
Beam Therapeutics appoints Sravan Emany as CFO
PremiumThe Fly
Beam Therapeutics appoints Sravan Emany as CFO
16d ago
BEAM
IRWD
Ironwood Pharmaceuticals Reports Q3 2024 Performance
PremiumCompany Announcements
Ironwood Pharmaceuticals Reports Q3 2024 Performance
1M ago
IRWD
Ironwood reports Q3 EPS, 2c consensus 8c
PremiumThe Fly
Ironwood reports Q3 EPS, 2c consensus 8c
1M ago
IRWD
IRWD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
IRWD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
IRWD
Ironwood to present new findings from STARS trial at ACG
PremiumThe FlyIronwood to present new findings from STARS trial at ACG
2M ago
IRWD
Ironwood initiated with a Market Perform at Leerink
Premium
The Fly
Ironwood initiated with a Market Perform at Leerink
3M ago
IRWD
Ironwood price target lowered to $10 from $14 at Craig-Hallum
Premium
The Fly
Ironwood price target lowered to $10 from $14 at Craig-Hallum
4M ago
IRWD
Ironwood price target lowered to $12 from $14 at Wells Fargo
PremiumThe Fly
Ironwood price target lowered to $12 from $14 at Wells Fargo
4M ago
IRWD
Warner Bros. writes down networks, Eli Lilly posts beat: Thursday Buzz
PremiumThe Fly
Warner Bros. writes down networks, Eli Lilly posts beat: Thursday Buzz
5M ago
UA
ARM
Ironwood downgraded to Equalweight from Overweight at Capital One
PremiumThe Fly
Ironwood downgraded to Equalweight from Overweight at Capital One
5M ago
IRWD
Palantir partners with Microsoft, Eli Lilly posts beat: Morning Buzz
PremiumThe Fly
Palantir partners with Microsoft, Eli Lilly posts beat: Morning Buzz
5M ago
BA
UA
Ironwood cuts FY24 revenue view to $350M-$375M from $405M-$425M
PremiumThe FlyIronwood cuts FY24 revenue view to $350M-$375M from $405M-$425M
5M ago
IRWD
Ironwood reports Q2 EPS 0c, consensus 15c
Premium
The Fly
Ironwood reports Q2 EPS 0c, consensus 15c
5M ago
IRWD
Is IRWD a Buy, Before Earnings?
Premium
Pre-Earnings
Is IRWD a Buy, Before Earnings?
5M ago
IRWD
Ironwood Pharma Elevates CFO and Repays Convertible Notes
PremiumCompany Announcements
Ironwood Pharma Elevates CFO and Repays Convertible Notes
6M ago
8K
IRWD
Ironwood’s apraglutide meets Phase 3 endpoint in Short Bowel Syndrome
PremiumThe Fly
Ironwood’s apraglutide meets Phase 3 endpoint in Short Bowel Syndrome
7M ago
IRWD
Ironwood Pharmaceuticals’ (NASDAQ:IRWD) Challenges Continue with Q1 Misses
PremiumMarket News
Ironwood Pharmaceuticals’ (NASDAQ:IRWD) Challenges Continue with Q1 Misses
7M ago
IRWD
Ironwood price target lowered to $14 from $18 at Craig-Hallum
PremiumThe Fly
Ironwood price target lowered to $14 from $18 at Craig-Hallum
8M ago
IRWD
Ironwood reports Q1 EPS (2c), consensus 19c
PremiumThe FlyIronwood reports Q1 EPS (2c), consensus 19c
8M ago
IRWD
Is IRWD a Buy, Before Earnings?
Premium
Pre-Earnings
Is IRWD a Buy, Before Earnings?
8M ago
IRWD
Ironwood management to meet with Craig-Hallum
Premium
The Fly
Ironwood management to meet with Craig-Hallum
9M ago
IRWD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >